SLC27A2 and neoplasm: In the subcutaneous tumors generated by COLO679 engraftment, tumor size and positivity for MelanA, a specific marker of melanoma, were significantly lower in the SLC27A2-overexpressing group (SLC27A2-COLO679) than in the control group (Fig. 5C–F).